# Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

> **NCT04002349** · NA · UNKNOWN · sponsor: **Beijing Tongren Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Determination of the Efficacy of Different Medications for Idiopathic Rhinitis
- Impact of Different Medications on Biomarkers of Idiopathic Rhinitis
- Safety and Tolerance of Different Medications for Idiopathic Rhinitis

## Interventions

- **DRUG:** Budesonide Nasal Spray (Rhinocort, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.)
- **DRUG:** Levocabastine Nasal Spray (Livostine, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.)
- **DRUG:** 0.9% natural saline

## Key facts

- **NCT ID:** NCT04002349
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002349, "Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04002349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*